Hussman Strategic Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-75,600	Closed	-$2.19M	–	269
2023 Q4	$2.19M	Sell	75,600 -18,000	-19%	-$521K	0.5%	78
2023 Q3	$2.58M	Hold	93,600	–	–	0.49%	76
2023 Q2	$2.81M	Buy	93,600 +600	+0.6%	+$18K	0.52%	52
2023 Q1	$3.37M	Sell	93,000 -31,000	-25%	-$1.12M	0.53%	56
2022 Q4	$4.42M	Hold	124,000	–	–	0.72%	28
2022 Q3	$4.2M	Sell	124,000 -6,000	-5%	-$203K	0.72%	27
2022 Q2	$3.76M	Buy	130,000 +26,000	+25%	+$752K	0.65%	31
2022 Q1	$3.36M	Hold	104,000	–	–	0.65%	38
2021 Q4	$3.03M	Buy	104,000 +11,000	+12%	+$321K	0.67%	33
2021 Q3	$2.48M	Hold	93,000	–	–	0.55%	52
2021 Q2	$2.86M	Sell	93,000 -51,000	-35%	-$1.57M	0.59%	44
2021 Q1	$3.77M	Buy	144,000 +93,000	+182%	+$2.43M	0.78%	14
2020 Q4	$1.28M	Buy	51,000 +36,000	+240%	+$906K	0.34%	117
2020 Q3	$313K	Hold	15,000	–	–	0.08%	239
2020 Q2	$356K	Hold	15,000	–	–	0.09%	238
2020 Q1	$270K	Hold	15,000	–	–	0.07%	249
2019 Q4	$356K	Sell	15,000 -10,000	-40%	-$237K	0.11%	177
2019 Q3	$687K	Hold	25,000	–	–	0.19%	153
2019 Q2	$827K	Sell	25,000 -15,000	-38%	-$496K	0.23%	143
2019 Q1	$1.4M	Sell	40,000 -25,000	-38%	-$876K	0.34%	123
2018 Q4	$2.16M	Buy	65,000 +15,000	+30%	+$498K	0.52%	82
2018 Q3	$2.52M	Hold	50,000	–	–	0.73%	54
2018 Q2	$2.99M	Hold	50,000	–	–	0.81%	38
2018 Q1	$2.29M	Buy	+50,000	New	+$2.29M	0.63%	77